CLASS II ONGOING Device recall · Reported 15 Nov 2023 · FDA Enforcement Report

Allergan Universal Fill Kit recalled by B. Braun Medical

B. Braun Medical is recalling Allergan Universal Fill Kit, distributed nationwide in the US. The recall was initiated on 26 Sep 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 4046964823749 Lot 0061745499, 0061745500, 0061745501, 0061792770
Quantity recalled27.432 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0134-2024
FDA event ID
93074
Recalling firm
B. Braun Medical, Allentown, PA
Classification
Class II
Status
Ongoing
Recall initiated
26 Sep 2023
FDA classified
3 Nov 2023
Reported
15 Nov 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects
Device type
Breast Implants

Timeline

26 Sep 2023Recall initiated by company
3 Nov 2023Classified by FDA+38 days
15 Nov 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Devices may leak as a result of a manufacturing issue. Leakage may result in a delay of therapy, increase risk of bloodstream infection (BSI), and may expose both patients and healthcare workers to hazardous medication. There is also the potential for life-threatening situations to occur requiring additional medical intervention.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

ALLERGAN UNIVERSAL FILL KIT, REF No. 7M2804. for tissue expander inflation.

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Canada and Singapore.

Nationwide

Questions about this recall

Why was it recalled?

Devices may leak as a result of a manufacturing issue. Leakage may result in a delay of therapy, increase risk of bloodstream infection (BSI), and may expose both patients and healthcare workers to hazardous medication. There is also the potential for life-threatening situations to occur requiring additional medical intervention.

Which lots are affected?

UDI-DI: 4046964823749 Lot 0061745499, 0061745500, 0061745501, 0061792770

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Canada and Singapore.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

8 other products · FDA event 93074

This product is part of a recall event; the main page for the event is Terumo 60" Tube Set W/High Crack Chk Vlv, Article No. 7S3070 recalled.

More recalls from B. Braun Medical

All 448

Other Breast Implants recalls

All 29